I am 32 weeks pregnant with a glucose tolerance test showing fasting 99 mg/dL, 1‑hour 210 mg/dL, 2‑hour 175 mg/dL, and 3‑hour 72 mg/dL; how should I manage gestational diabetes mellitus (GDM)?

Management of Gestational Diabetes at 32 Weeks with Abnormal Glucose Tolerance Test

You have gestational diabetes mellitus (GDM) requiring immediate treatment with lifestyle modifications (medical nutrition therapy and exercise), and you should start insulin therapy if your home glucose monitoring shows fasting values ≥95 mg/dL or 1-hour postprandial values ≥140 mg/dL on more than one occasion. 1

Diagnosis Confirmation

Your 3-hour glucose tolerance test results confirm GDM because you have two abnormal values (fasting 99 mg/dL exceeds the 92 mg/dL threshold, 1-hour 210 mg/dL exceeds 180 mg/dL, and 2-hour 175 mg/dL exceeds 153 mg/dL)—only one elevated value is needed for diagnosis. 2

Immediate Management Steps

Start Lifestyle Modifications First

• Begin medical nutrition therapy with nutritional counseling immediately; this is the mandatory first-line treatment for all women with GDM. 3, 2
• Increase physical activity to moderate intensity levels unless contraindicated by obstetric concerns. 2
• Initiate daily self-monitoring of blood glucose: measure fasting glucose every morning and either 1-hour or 2-hour postprandial readings after each meal. 1

Glycemic Targets for Home Monitoring

Your glucose goals are:

• Fasting: <95 mg/dL 1, 2
• 1-hour postprandial: <140 mg/dL 1, 2
• 2-hour postprandial: <120 mg/dL 1

These targets apply whether you remain on lifestyle therapy alone or require medication. 1

When to Start Insulin

Your fasting glucose of 99 mg/dL on the diagnostic test is a strong predictor that you will likely need insulin. Research shows that a fasting glucose ≥105 mg/dL has 91.89% specificity and 80.64% positive predictive value for requiring insulin during pregnancy, and your value of 99 mg/dL approaches this threshold. 4

Insulin Initiation Criteria

Start insulin if home monitoring shows:

• Fasting glucose >95 mg/dL on more than one occasion, OR 2
• 1-hour postprandial glucose >140 mg/dL repeatedly, OR 2
• 2-hour postprandial glucose >120 mg/dL three times in one week 5

Medication Choice

• Insulin is the recommended first-line pharmacologic therapy for GDM when lifestyle modifications fail to maintain target glucose levels. 6, 3
• The American Diabetes Association endorses insulin as first-line treatment because it is safe for the fetus and newborn. 6
• Although metformin and glyburide are alternatives if you are unable or unwilling to use insulin, insulin remains preferred due to concerns about long-term metabolic effects of oral agents on offspring (metformin crosses the placenta at ~70% of maternal levels, and long-term offspring outcomes are less well known). 6

Fetal Surveillance

• Begin fetal surveillance at 32 weeks of gestation (which is now) because you will likely require medication given your elevated fasting glucose. 3
• This typically includes non-stress testing and/or biophysical profiles, though the exact protocol should follow your obstetric provider's recommendations. 3
• Monitor for fetal macrosomia (estimated fetal weight >4,000 g) with ultrasound assessments. 3

Delivery Planning

Timing of Delivery

• If you achieve glucose control with lifestyle modifications alone: plan delivery between 39 weeks 0 days and 40 weeks 6 days. 3
• If you require insulin or other medications: plan delivery between 39 weeks 0 days and 39 weeks 6 days (a narrower window). 3

Cesarean Delivery Considerations

• Discuss risks and benefits of prelabor cesarean delivery if estimated fetal weight exceeds 4,500 g to reduce shoulder dystocia risk. 3

Postpartum Follow-Up

• Undergo a 75-g oral glucose tolerance test 4–12 weeks postpartum to reclassify your glucose tolerance status, as insulin resistance typically resolves after delivery. 3, 2
• If postpartum testing is normal, repeat screening every 2 years because you have a sevenfold increased relative risk of developing type 2 diabetes. 2
• Continue lifestyle modifications, breastfeed if possible, and consider metformin postpartum—all reduce your long-term diabetes risk. 3, 7

Common Pitfalls to Avoid

• Do not rely solely on A1C measurements during pregnancy; A1C underestimates postprandial hyperglycemia (the main driver of fetal macrosomia) due to increased red-cell turnover in pregnancy. 1
• Do not delay insulin initiation if home glucose values exceed targets; early glycemic control is critical to prevent complications like macrosomia, shoulder dystocia, and neonatal hypoglycemia. 3
• Do not assume you can avoid medication based on your 3-hour test alone; your fasting value of 99 mg/dL strongly suggests you will need insulin, so prepare for this likelihood. 4

Optional: Continuous Glucose Monitoring

• Continuous glucose monitoring (CGM) may be beneficial and has been shown to reduce HbA1c and macrosomia rates in GDM, but it should not replace your daily fasting and postprandial fingerstick measurements for insulin dose adjustments. 1, 8
• CGM time-in-range targets (63–140 mg/dL >70%) are useful adjuncts but are not substitutes for specific glucose targets. 1